Ponatinib is a tyrosine kinase inhibitor used in the treatment of certain types of leukemia, such as chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). One of the side effects that can occur with ponatinib therapy is a skin rash, which can ...
Ponatinib is a tyrosine kinase inhibitor used in the treatment of certain types of leukemia, such as chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemi ...